Weiguo Qing
Corporate Officer/Principal bei Hutchison MediPharma Ltd.
Aktive Positionen von Weiguo Qing
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01.01.2008 | - |
Karriereverlauf von Weiguo Qing
Ehemalige bekannte Positionen von Weiguo Qing
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
| Roche Corp. | Corporate Officer/Principal | - | - |
Ausbildung von Weiguo Qing
| The University of Texas at Austin | Doctorate Degree |
| Institute of Materia Medica | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Corp. |
- Börse
- Insiders
- Weiguo Qing
- Erfahrung
